Neuroone Medical Technologies Stock Analysis
| NMTC Stock | USD 1.04 0.02 1.96% |
Neuroone Medical Technologies is overvalued with Real Value of 0.8 and Hype Value of 1.04. The main objective of Neuroone Medical stock analysis is to determine its intrinsic value, which is an estimate of what Neuroone Medical Technologies is worth, separate from its market price. There are two main types of Neuroone Medical's stock analysis: fundamental analysis and technical analysis.
The Neuroone Medical stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Neuroone Medical's ongoing operational relationships across important fundamental and technical indicators.
Neuroone |
Neuroone Stock Analysis Notes
About 16.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.46. Neuroone Medical Tec had not issued any dividends in recent years. The entity had 1:3 split on the 1st of April 2021. NeuroOne Medical Technologies Corporation operates as a medical technology company. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator for use with NeuroOnes combination recording and ablation electrode to record brain activity and ablate brain tissue using the same electrode. Neuroone Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 11 people. To find out more about Neuroone Medical Technologies contact David MD at 952 426 1383 or learn more at https://www.n1mtc.com.Neuroone Medical Tec Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Neuroone Medical's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Neuroone Medical Technologies or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Neuroone Medical Tec had very high historical volatility over the last 90 days | |
| Neuroone Medical Tec has some characteristics of a very speculative penny stock | |
| The company reported the previous year's revenue of 3.45 M. Net Loss for the year was (12.32 M) with loss before overhead, payroll, taxes, and interest of (4.6 M). | |
| Neuroone Medical Technologies currently holds about 10.18 M in cash with (11.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.63. | |
| Roughly 16.0% of the company outstanding shares are owned by corporate insiders |
Neuroone Medical Tec Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Neuroone Medical previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 12th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Neuroone Medical Thematic Classifications
In addition to having Neuroone Medical stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | Medical EquipmentUSA Equities from Medical Equipment industry as classified by Fama & French |
Neuroone Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 31.46 M.Technical Drivers
As of the 22nd of January, Neuroone Medical secures the Downside Deviation of 5.24, risk adjusted performance of 0.0433, and Mean Deviation of 4.8. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Neuroone Medical Tec, as well as the relationship between them.Neuroone Medical Tec Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Neuroone Medical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Neuroone Medical Tec. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Neuroone Medical Tec Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Neuroone Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Neuroone Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Neuroone Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Neuroone Medical Outstanding Bonds
Neuroone Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Neuroone Medical Tec uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Neuroone bonds can be classified according to their maturity, which is the date when Neuroone Medical Technologies has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Neuroone Medical Predictive Daily Indicators
Neuroone Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Neuroone Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Neuroone Medical Forecast Models
Neuroone Medical's time-series forecasting models are one of many Neuroone Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Neuroone Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Neuroone Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Neuroone Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Neuroone shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Neuroone Medical. By using and applying Neuroone Stock analysis, traders can create a robust methodology for identifying Neuroone entry and exit points for their positions.
NeuroOne Medical Technologies Corporation operates as a medical technology company. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator for use with NeuroOnes combination recording and ablation electrode to record brain activity and ablate brain tissue using the same electrode. Neuroone Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 11 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Neuroone Medical to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Watchlist Optimization Now
Watchlist OptimizationOptimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
| All Next | Launch Module |
Complementary Tools for Neuroone Stock analysis
When running Neuroone Medical's price analysis, check to measure Neuroone Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neuroone Medical is operating at the current time. Most of Neuroone Medical's value examination focuses on studying past and present price action to predict the probability of Neuroone Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neuroone Medical's price. Additionally, you may evaluate how the addition of Neuroone Medical to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |